CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Nanopath
Nanopath logo

Nanopath

Nanopath: A molecular diagnostics firm revolutionizing testing for women's health in a single visit.

Cambridge, MA, US🇺🇸
Founded
2019
Overview
Compare
Fundraising
Employees
Library

Founded with the mission to revolutionize molecular diagnostics, Nanopath focuses on providing rapid and clinically actionable information to improve women's health. Their innovative technology aims to deliver comprehensive diagnostic results within a single office visit, addressing the limitations of traditional testing methodologies. Nanopath's market focus is on women's health, aiming to offer more precise and timely diagnostics to enhance patient outcomes.

Notable affiliated individuals include experts in molecular diagnostics and healthcare innovation. The company has garnered attention from key investors in the biotech and healthcare sectors, aiding in its technological advancements. Nanopath's significant achievements include the development of breakthrough diagnostic technologies that promise to transform the current diagnostic landscape. Their impact lies in offering equitable and improved healthcare solutions, particularly for women, through faster and more accurate diagnostics.

Nanopath - Similar Companies

Ovagene Oncology logo

Ovagene Oncology

Nanoscope Technologies logo

Nanoscope Technologies

NAT Diagnostics logo

NAT Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Hera Biotech logo

Hera Biotech

herabiotech.com

Minute Molecular Diagnostics logo

Minute Molecular Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

NanoDx logo

NanoDx

Caza Health logo

Caza Health

cazahealth.com

NanoMosaic logo

NanoMosaic

NanoCytomics logo

NanoCytomics

nano-cytomics.com

Biomirror Diagnostics logo

Biomirror Diagnostics

Molecular Biometrics logo

Molecular Biometrics

Signatur Biosciences logo

Signatur Biosciences

signatur.bio

OmniVis logo

OmniVis

omnivistech.com

Nanopath - Quick Facts

Who are Nanopath's competitors?

Companies similar to Nanopath include Ovagene Oncology, Nanoscope Technologies, NAT Diagnostics and Prompt Diagnostics.

When was Nanopath founded?

Nanopath was founded in 2019.

Where is Nanopath's headquarters located?

Nanopath's headquarters is located in Cambridge, MA, US.

When was Nanopath's last funding round?

Nanopath's most recent funding round was for $10M (USD) in August 2022.

How much disclosed funding has Nanopath raised?

As of Aug 9, 2022, Nanopath has disclosed funding of $10.3M (USD). Undisclosed round amounts are excluded.

How many employees does Nanopath have?

Nanopath has 30 employees as of Feb 5, 2024.

Nanopath - Classification

Ownership
  • Private
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Womens Health
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research